Rosato, RPh, IOM, on the Centers for Medicaid and Medicare Services’ recently released Progress Notice of Methodological Changes for Calendar Year 2016 for Medicare Benefit Capitation Rates, Part C and Part D Payment Plans and 2016 Call Letter: We are very happy to see that CMS won’t take any significant actions on preferred pharmacy networks, and will allow Medicare Component D plans to continue to create effective pharmacy systems that save customers and the federal government money. This placement is in keeping with AMCP’s perspective that preferred pharmacy systems promote market competition by serving seeing that an instrument to encourage affordable usage of medications through negotiations between Component D plans and pharmacies.She received a 2013 Presidential Commendation from the American Academy of Pain Medicine. Tacrolimus is usually a calcineurin inhibitor often used in patients to greatly help prevent organ rejection. For continued organ survival, a transplant patient must be monitored accurately and exactly to guarantee the medication level is sufficient to prevent organ rejection also to help the organ remain functional. Currently, test strategies used to monitor tacrolimus concentration in the blood aren’t standardized which may result in varying results for sufferers. Underestimating tacrolimus levels you could end up prescribing unnecessarily high dosages of medication that may be toxic to the transplanted organ over time and may cause unwanted effects contributing to a poor standard of living for the patient.